ImmunityBio, Inc.

NASDAQ:IBRX

2.71 (USD) • At close June 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q2
Revenue 16.5177.5526.1061.0470.040.1390.0820.0410.360.0730.1180.0350.0140.390.0660.3390.139-0.1470.1510.4360.1650.920.0120.0170.0050.0070.0310.0040.0050.0120.0080.0140.0110.0140.0120.0120.0060.0140.010.091
Cost of Revenue 0.0580004.5554.5644.5856.3186.2786.8785.9755.9315.408000000000000000000000000000
Gross Profit 16.4593.4146.1061.047-4.515-4.425-4.503-6.277-5.918-6.805-5.857-5.896-5.3940.390.0660.3390.139-0.1470.1510.4360.1650.920.0120.0170.0050.0070.0310.0040.0050.0120.0080.0140.0110.0140.0120.0120.0060.0140.010.091
Gross Profit Ratio 0.9960.45211-112.875-31.835-54.915-153.098-16.439-93.219-49.636-168.457-385.286111111111111111111111111111
Reseach & Development Expenses 45.97635.22150.44351.12952.85151.03248.40253.16879.26458.07771.61263.08255.37851.75349.27753.841.12843.35635.77233.00527.37413.19312.05213.13112.59812.4814.55914.68813.99112.02111.0699.7069.2489.4458.3646.3894.9445.1063.951.745
General & Administrative Expenses 0000000000000000000008.3264.0254.1825.7425.2469.5813.59414.29813.38513.38114.12816.22715.71324.42328.58826.65174.83138.85482.429
Selling & Marketing Expenses 0000000000000000000000.2000000000000000000
SG&A 31.97741.73135.91649.25137.8329.04631.81632.01832.67626.21519.3116.57540.60827.91129.62532.44545.27523.88219.59618.3479.4938.5264.0254.1825.7425.2469.5813.59414.29813.38513.38114.12816.22715.71324.42328.58826.65174.83138.85482.429
Other Expenses 2.935000-0.02-37.0236.47-6.796-1.077-0.9230.0060.185-0.004-0.059-0.0380.2770.0130.2170.0840.0811.1040000000000000000000
Operating Expenses 80.88876.95286.359100.3890.68180.07880.21885.186111.9484.29290.92279.65795.98679.66478.90286.24586.40367.23855.36851.35236.86721.69416.07717.31318.3417.72624.13928.28228.28925.40624.4523.83425.47525.15832.78734.97731.59579.93742.80484.174
Operating Income -64.429-69.4-80.253-99.333-95.196-84.503-80.136-85.145-111.58-84.9-90.804-79.622-95.972-79.274-78.836-85.906-86.264-67.385-65.877-50.916-36.702-21.357-15.576-16.68-17.918-17.323-23.614-27.749-27.61-24.625-23.675-23.422-24.576-24.35-31.92-34.225-30.793-77.123-42.649-84.581
Operating Income Ratio -3.901-9.19-13.143-94.874-2,379.9-607.935-977.268-2,076.707-309.944-1,163.014-769.525-2,274.914-6,855.143-203.267-1,194.485-253.41-620.604458.401-436.272-116.78-222.436-23.214-1,298-981.176-3,583.6-2,474.714-761.742-6,937.25-5,522-2,052.083-2,959.375-1,673-2,234.182-1,739.286-2,660-2,852.083-5,132.167-5,508.786-4,264.9-929.462
Total Other Income Expenses Net -65.21710.238-5.499-35.251-38.934-148.951-15.506-53.068-5.003-23.392-20.357-15.213-7.026-12.278-9.593-3.4775.789-10.944-12.653-1.056-0.707-0.9020.4840.616-0.003-0.1450.345-0.1060.6410.735-0.3930.244-0.0370.757-0.0290.740.79600.145-0.498
Income Before Tax -129.646-59.179-85.752-134.584-134.13-233.454-95.582-138.213-116.583-108.292-111.161-94.835-102.998-91.552-88.429-89.383-80.475-68.782-67.87-51.972-37.409-22.259-15.581-16.68-17.921-17.468-23.763-27.855-27.643-24.659-24.068-23.576-24.613-24.387-31.949-34.225-30.793-77.123-42.649-84.581
Income Before Tax Ratio -7.849-7.836-14.044-128.543-3,353.25-1,679.525-1,165.634-3,371.049-323.842-1,483.452-942.042-2,709.571-7,357-234.749-1,339.833-263.667-578.957467.905-449.47-119.202-226.721-24.195-1,298.417-981.176-3,584.2-2,495.429-766.548-6,963.75-5,528.6-2,054.917-3,008.5-1,684-2,237.545-1,741.929-2,662.417-2,852.083-5,132.167-5,508.786-4,264.9-929.462
Income Tax Expense 00.01700-0.021-0.04-4.58520.88834.5790.034-0.2235.282-0.1720.001-0.80.0020.006-0.209-1.70.0450.0180.0080.0050.002-0.036-0.128-0.128-0.123-0.124-0.172-0.099-0.124-0.098-0.149-0.052-0.228-0.143-0.3020.145-0.498
Net Income -129.646-59.162-85.729-134.564-134.109-233.392-95.582-137.879-151.162-108.326-110.938-94.588-102.826-91.259-87.629-88.288-79.614-67.771-65.603-51.439-37.038-22.276-15.586-16.682-17.885-17.34-23.635-27.732-27.519-24.487-23.969-23.452-24.515-24.238-31.897-33.997-30.65-76.821-42.649-84.581
Net Income Ratio -7.849-7.834-14.04-128.523-3,352.725-1,679.079-1,165.634-3,362.902-419.894-1,483.918-940.153-2,702.514-7,344.714-233.997-1,327.712-260.437-572.763461.027-434.457-117.979-224.473-24.213-1,298.833-981.294-3,577-2,477.143-762.419-6,933-5,503.8-2,040.583-2,996.125-1,675.143-2,228.636-1,731.286-2,658.083-2,833.083-5,108.333-5,487.214-4,264.9-929.462
EPS -0.15-0.095-0.14-0.2-0.2-0.35-0.19-0.32-0.35-0.27-0.28-0.24-0.26-0.23-0.22-0.23-0.21-0.18-0.17-0.13-0.097-0.067-0.04-0.042-0.055-0.053-0.075-0.088-0.087-0.078-0.075-0.072-0.075-0.074-0.097-0.1-0.094-0.24-0.14-0.27
EPS Diluted -0.15-0.095-0.14-0.2-0.2-0.35-0.19-0.32-0.35-0.27-0.28-0.24-0.26-0.23-0.22-0.23-0.21-0.18-0.17-0.13-0.097-0.067-0.04-0.042-0.055-0.053-0.075-0.088-0.087-0.078-0.075-0.072-0.075-0.074-0.097-0.1-0.094-0.24-0.14-0.27
EBITDA -64.429-17.467-41.066-91.159-92.088-196.764-56.036-99.4-80.749-72.879-90.804-79.622-90.437-81.877-79.863-81.822-72.555-55.612-51.663-47.418-33.241-13.484-13.374-15.098-14.859-14.536-20.838-25.38-25.987-23.056-22.214-22.048-23.414-22.511-31.15-33.712-30.308-76.718-42.624-83.592
EBITDA Ratio -3.901-2.313-6.726-87.067-2,302.2-1,415.568-683.366-2,424.39-224.303-998.342-769.525-2,274.914-6,459.786-209.941-1,210.045-241.363-521.978378.313-342.139-108.757-201.461-14.657-1,114.5-888.118-2,971.8-2,076.571-672.194-6,345-5,197.4-1,921.333-2,776.75-1,574.857-2,128.545-1,607.929-2,595.833-2,809.333-5,051.333-5,479.857-4,262.4-918.593